The Definitive Peptide Research Reference Guide — Compound Review

Home Compounds BPC-157 TB-500 CJC-1295 Ipamorelin GLP-1 GHK-Cu Epithalon NAD+ Comparisons BPC-157 vs TB-500 Sermorelin vs Ipamorelin Semaglutide vs Tirzepatide Guides GHK-Cu Guide GHRH Analogues Ipamorelin Guide Semaglutide Dosage BPC-157 Dosage Research Guides Joint Pain Weight Loss Longevity Shop Purgo Labs

Retatrutide vs Tirzepatide Weight Loss: ~24% vs ~22% Data Compared (2026)

Retatrutide vs tirzepatide weight loss — Phase 2 (~24.2%) vs SURMOUNT-1 (~22%, Phase 3) data, triple vs dual agonist mechanism, Phase 2 caveat, nausea comparison, and FDA approval status.